Ryan McDonnell’s articles from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP are most popular: in European Union Finnegan, Henderson, Farabow, Garrett & Dunner, LLP are most popular: within Government and Public Sector topic(s) In Ollnova Technologies Ltd., v. ecobee Technologies ULC, No. 2025-1045, 2025-1046 (Fed. Cir.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ryan McDonnell
Federal Circuit Reinforces Injury-in-Fact Requirement In Appeals From Post-Grant Proceedings
In ironSource Ltd. v. Digital Turbine, Inc., No. 2024-1831 (Fed. Cir. Apr. 7, 2026), the Federal Circuit dismissed ironSource’s appeal from a post‑grant review (PGR) decision for lack of Article III standing. ironSource petitioned for PGR of Digital Turbine’s patent, which relates to downloading and installing mobile device applications in the background instead of directing a user to an application store, asserting unpatentability under 35 U.S.C. §§ 101, 102, and 103.
Federal Circuit Affirms Indefiniteness Of The Term “About”
Christine M. Akagi’s articles from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP are most popular: with Inhouse Counsel in United States with readers working within the Insurance, Healthcare and Retail & Leisure industries In Enviro Tech Chemical Services, Inc., v. Safe Foods Corp., No. 2024-2160 (Fed. Cir. May 4, 2026), the Federal Circuit affirmed a district court’s determination that all asserted claims of U.S. Patent No. 10,912,321 were invalid as indefinite.
Federal Circuit Affirms Indefiniteness of the Term “About”
In Enviro Tech Chemical Services, Inc., v. Safe Foods Corp., No. 2024-2160 (Fed. Cir. May 4, 2026), the Federal Circuit affirmed a district court’s determination that all asserted claims of U.S. Patent No. 10,912,321 were invalid as indefinite. Enviro Tech sued Safe Foods for infringement of the ’321 patent, which relates to methods of treating poultry during processing to increase weight. The asserted claims recite “a pH of about 7.6 to 10,” and Safe Foods argued that the term “about” is indefinite.
Federal Circuit Reinforces Injury-in-Fact Requirement in Appeals from Post-Grant Proceedings
In ironSource Ltd. v. Digital Turbine, Inc., No. 2024-1831 (Fed. Cir. Apr. 7, 2026), the Federal Circuit dismissed ironSource’s appeal from a post‑grant review (PGR) decision for lack of Article III standing. ironSource petitioned for PGR of Digital Turbine’s patent, which relates to downloading and installing mobile device applications in the background instead of directing a user to an application store, asserting unpatentability under 35 U.S.C. §§ 101, 102, and 103.
The Power Of Policy: Fintiv Remains Intact At The PTAB
In Apple Inc. v. Squires, No. 24-1864 (Fed. Cir. Feb. 13, 2026), the Federal Circuit affirmed the Northern District of California's ruling that the USPTO Director's NHK-Fintiv framework for discretionary denial of inter partes review petitions is a “general statement of policy” exempt from the Administrative Procedure Act's (“APA”) notice-and-comment requirements.
Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards In Hikma v. Amarin
Supreme Court to Clarify Skinny‑Label Inducement: The Court took Hikma to decide when a generic drug maker can be liable for inducing infringement even after carving out a patented indication. Case Centers on Non‑Label Conduct:Because Hikma fully removed the patented use from its label, the issue is whether marketing statements and press releases alone can show inducement.
$85 Million Verdict Affirmed: Federal Circuit Shuts Down Ingevity's Challenge To Antitrust Verdict
InIngevity Corp. v. BASF Corp., No. 2024-1577 (Fed. Cir. Feb. 11, 2026), the Federal Circuit affirmed an $85 million trebled jury verdict against Ingevity for unlawful tying under the Sherman Act. Ingevity initially sued BASF for infringing U.S. Patent No. RE38,844 ("the '844 Patent") but the district court determined that the patent was invalid on summary judgment leaving only BASF's counterclaims for antitrust and tortious interference for a jury trial.
Nearest Referent, Nearest Resolution: Federal Circuit Clarifies Encryption Claim Language
In Netflix, Inc. v. DivX, LLC, No. 24-1541 (Fed. Cir. Feb. 13, 2026), the Federal Circuit reversed the Patent Trial and Appeal Board's claim construction, vacated its final written decision, and remanded for further proceedings. Netflix petitioned for an inter partes review of DivX's patent, asserting obviousness over a combination of prior art.
"Template For Tailoring" Falls On Losing Side Of Computer-Based Patent Eligibility Divide
In GoTV Streaming, LLC v. Netflix, Inc., No. 24-1669 (Fed. Cir. Feb. 9, 2026), the Federal Circuit reversed a district court's holding that GoTV's claims were patent eligible under 35 U.S.C. § 101. GoTV asserted against Netflix three patents directed to tailoring content presentation to a particular wireless device's screen size or other capabilities. Netflix moved for judgment on the pleadings that the asserted claims were subject-matter ineligible under § 101.
Skinny labels, larger risks: Supreme Court considers induced infringement standards in Hikma v. Amarin
(March 03, 2026) - Charles Collins-Chase and Ryan McDonnell of Finnegan, Henderson, Farabow, Garrett & Dunner LLP discuss the Supreme Court's consideration of induced infringement standards for "skinny labels." On January 16, 2026, the Supreme Court granted a petition for writ of certiorari in Hikma Pharmaceuticals USA Inc. v.
Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin
Supreme Court to Clarify Skinny‑Label Inducement: The Court took Hikma to decide when a generic drug maker can be liable for inducing infringement even after carving out a patented indication. Case Centers on Non‑Label Conduct:Because Hikma fully removed the patented use from its label, the issue is whether marketing statements and press releases alone can show inducement.
Federal Circuit Upholds PTAB Recusal, Remands To Consider Copying Evidence
In Centripetal Networks, LLC v. Palo Alto Networks, Inc., No. 23-2027 (Fed. Cir. Oct. 22, 2025), the Federal Circuit found no reversible error in the PTAB's recusal analysis and vacated and remanded the PTAB's obviousness judgment for further proceedings to properly consider evidence of copying.
Federal Circuit Affirms-in-Part And Vacates-In-Part PTAB Unpatentability Findings Based On Claim Construction
In Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., No. 23-2434 (Fed. Cir. Sept. 23, 2025), the Federal Circuit affirmed the PTAB's judgment holding claims 1-4 of U.S. Patent No. 10,828,310 unpatentable and vacated and remanded the judgment holding claims 5-8 unpatentable. Claims 1-4 recite, among other things, methods of administering rivaroxaban and aspirin in amounts "clinically proven effective" at reducing the risk of certain conditions.
Federal Circuit Vacates TTAB Decision Finding Likelihood Of Confusion And Remands For Further Analysis Of Third-Party Uses Of Similar Marks In Use On Similar Services
Caleb D. Estes’s articles from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP are most popular: within Intellectual Property topic(s) in United States with readers working within the Retail & Leisure industries In Apex Bank v. CC Serve Corp., No. 2023-2143 (Fed. Cir. Sept. 25, 2025), the Federal Circuit vacated and remanded a TTAB decision refusing to register Apex's trademark based on likelihood of confusion.
Unclear Expert Testimony Leads To Reversal Of JMOL Denial And Vacatur Of $166 Million Damages Award
In Finesse Wireless LLC v. AT&T Mobility LLC, No. 2024-1039 (Fed. Cir. Sept. 24, 2025), the Federal Circuit reversed the district court's denial of AT&T's motion for JMOL of noninfringement and vacated the associated damages award. Finesse asserted two patents claiming methods for mitigating intermodulation product interference in radios against AT&T. The jury found all asserted claims valid and infringed and awarded Finesse $166,303,391 in damages.
Federal Circuit Upholds Prosecution Laches In Ruling Against Gilbert Hyatt
In Hyatt v. Stewart, Nos. 2018-2390 et al. (Fed. Cir. Aug. 29, 2025), the Federal Circuit affirmed the district court's judgment for the PTO, holding that prosecution laches barred Gilbert Hyatt's claims in four long-pending patent applications. In the early 1970s, Hyatt filed nearly 400 patent applications, four of which are at issue. In each, the examiner rejected most claims, Hyatt appealed to the Board, and the Board affirmed rejections of certain claims.
Federal Circuit Affirms PTAB In First Ever Review Of AIA Derivation Proceeding
In Global Health Solutions LLC v. Selner, No. 2023-2009 (Fed. Cir. Aug. 26, 2025), the Federal Circuit affirmed the PTAB's rejection of Global Health's AIA derivation claim because substantial evidence supported Selner's claim of independent conception. Selner and Global Health each filed a patent application under the AIA covering the same subject matter, but Selner filed its application first.
Federal Circuit Questions TTAB's Refusal To Register The F-Word
The Federal Circuit vacated and remanded the Trademark Trial and Appeal Board's decision affirming an examining attorney's refusal to register the word "FUCK" as a trademark in In re Brunetti, No. 2023-1539 (Fed. Cir. Aug. 26, 2025). The Federal Circuit agreed with most of the TTAB's reasoning in rejecting Brunetti's arguments but held that the TTAB's opinion lacked sufficient clarity to support its decision to reject Brunetti's application.
Federal Circuit Reverses JMOL Of No On-Sale Bar By Finding Abuse Of Discretion
In Jiaxing Super Lighting Electric Appliance Co. v. CH Lighting Technology Co., No. 23-1715 (Fed. Cir. July 28, 2025), the Federal Circuit affirmed the district court's judgment based on a jury verdict of infringement and validity of one patent, reversed the district court's grant of judgment as a matter of law that two other patents were not invalid due to an on-sale bar, and vacated the award of damages for all three patents.
Federal Circuit Vacates Preliminary Injunction Based On Erroneous Construction Of "Composition"
In FMC Corp. v. Sharda USA, LLC, No. 2024-2335 (Fed. Cir. Aug. 1, 2025), the Federal Circuit vacated a preliminary injunction and remanded because the district court abused its discretion due to an erroneous construction of the claim term "composition." FMC sought a temporary restraining order ("TRO") against Sharda for infringement of patents relating to insecticide and miticide compositions.
Federal Circuit Affirms PTAB's Rejection Of Reissue Patent For Online Advertising
In In re Kostic, No. 23-1437 (Fed. Cir. May 6, 2025), the Federal Circuit affirmed the PTAB's finding that a reissue application for an online advertising patent improperly broadened the original claim. The appellants filed a reissue application six years after the patent was granted. By statute, reissue applications filed more than two years after the grant of the original patent cannot broaden the scope of the original patent claims.
Federal Circuit Dismisses Appeal Regarding Real Parties In Interest For Lack Of Standing
In Dolby Laboratories Licensing Corporation v. Unified Patents, LLC, No. 2023-2110 (Fed. Cir. June 5, 2025), the Federal Circuit dismissed Dolby's appeal of a final written decision of the Patent Trial and Appeal Board for lack of Article III standing, determining that Dolby had not established a sufficient injury in fact.
Federal Circuit Affirms Claim Construction Where Patentee Acted As Lexicographer
In Alnylam Pharmaceuticals, Inc. v. Moderna Inc., No. 23-2357 (Fed. Cir. June 4, 2025), the Federal Circuit affirmed the district court's judgment that Moderna's SPIKEVAX®vaccine did not infringe two of Alnylam's patents. The dispute focused on the construction of the term "branched alkyl," which the parties agreed was dispositive of infringement.
Bitcoin Mining Patent Retains Original Inventorship
In Bearbox LLC v. Lancium LLC, No. 2023-1922 (Fed. Cir. January 13, 2025), the Federal Circuit affirmed, among other things, the district court's (1) determination that BearBox had not met its burden to establish sole or joint inventorship of Lancium's U.S. Patent No. 10,608,433 (the "'433 patent") and (2) grant of summary judgment dismissing BearBox's state law conversion claim as preempted by federal patent law.
Pre-Filing Private Sales Cannot Antedate Prior-Art References Under The § 102(b)(2)(B) "Public Disclosure" Exception
In Sanho Corp. v. Kaijet Technology International Ltd., Inc., No. 23-1336 (Fed. Cir. July 31, 2024), the Federal Circuit affirmed the Patent Trial and Appeal Board's decision that the inventor's pre-filing private sale of a product cannot be used to antedate a prior-art reference under the "public disclosure" exception in 35 U.S.C. § 102(b)(2)(B) (AIA) ("A disclosure made 1 year or less before the effective filing date of a claimed invention shall not be prior art to the claimed invention . . .
Silence Is Not Surrender: Federal Circuit Determines That Arguments Omitted In PTAB Rehearing Request Were Not Forfeited On Appeal
In Voice Tech Corp. v. Unified Patents, LLC, No. 22-2163 (Fed. Cir. Aug. 1, 2024), the Federal Circuit affirmed the Patent Trial and Appeal Board's decision that all challenged claims of Voice Tech's patent were unpatentable. The patent relates to using voice commands to remotely control a computer. Unified Patents petitioned for an inter partes review, asserting that the claims would have been obvious. The Board found all challenged claims unpatentable.
Federal Circuit Affirms Rejection Of Character Mark Citing Prior Use And Likelihood Of Confusion
In Araujo v. Framboise Holdings Inc., 99 F.4th 1377 (Fed. Cir. 2024), the Federal Circuit affirmed the Trademark Trial and Appeal Board's ("TTAB") decision sustaining Framboise's opposition and refusing registration of Araujo's standard character mark #TODECACHO. Araujo filed a trademark application to register #TODECACHO for hair combs. Framboise opposed Araujo's registration, alleging ownership of a #TODECACHO design mark based on its prior use of the mark for hair products.
No Consequence For Board Issuing Final Written Decision Over 37 Months After Institution
In Purdue Pharma L.P. v. Collegium Pharmaceutical, Inc., No. 22-1482 (Fed. Cir. Nov. 21, 2023), the Federal Circuit held that the Patent Trial and Appeal Board ("Board") has authority to issue a Final Written Decision ("FWD") after the deadline proscribed by 35 U.S.C. § 326(a)(11) and 37 C.F.R. §42.200(c) and affirmed the Board's finding that claims 1-17 of U.S. Patent No. 9,693,961 are invalid for lack of written description. The Board took over 37 months from institution to issue its FWD.
Podcast Series: Last Month At The Federal Circuit
Welcome to the Last Month at the Federal Circuit—a look at recent Federal Circuit decisions impacting the intellectual property community. In this episode, Cora Holt and Ryan McDonnell discuss recent cases from October. To listen to the podcast, click here. The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Characterization Of Reference As Primary Or Secondary Has No Effect On The Obviousness Analysis
In Schwendimann v. Neenah, Inc., No. 22-1333 (Fed. Cir. Oct. 6, 2023), the Federal Circuit affirmed the Patent Trial and Appeal Board's ("Board") holding that all claims of U.S. Patent Nos. RE41,623, 7,754,042, and 7,766,475 and claims 1–6, 8–21, and 24–31 of U.S. Patent No. 7,749,581 are unpatentable for obviousness in view of two prior-art references. The Federal Circuit addressed three issues on appeal.
When To Consider Expert Testimony For Special Purpose Computer-Implemented Means-Plus-Function Claims
In Sisvel International S.A. v. Sierra Wireless, Inc., Nos. 2022-1493, 2022-1547 (Fed. Cir. Oct. 6, 2023), the Federal Circuit affirmed-in-part, vacated-in-part, and remanded to the Patent Trial and Appeal Board ("Board"). Cross-Appellants filed a petition for an IPR of claims 1-10 of U.S. Patent No. 6,529,561 ("the '561 patent"). The '561 patent relates to methods of channel coding when transmitting data in radio systems.
Lidl swings to annual loss amid battle to keep prices low as costs surge
Sales jumped 18.8 per cent to £9.3bn over the year and the group said it increased its share of the supermarket sector. But it said the losses came as it faced a “challenging inflationary environment which led to an increase in costs across the board” and made significant investments in the chain.
Later Induced Infringement Claims May Not Be Barred By Earlier Direct Infringement Claims
In Inguran, LLC V. ABS Global, Inc., No. 22-1385 (Fed. Cir. July 5, 2023), the Federal Circuit reversed a district court's dismissal of Inguran's induced infringement claims based on res judicata and it's ruling on the scope of an ongoing royalty. In 2014, ABS filed an antitrust lawsuit ("ABS I") against Inguran, dba STGenetics, ("ST"). ST filed counterclaims alleging direct infringement of U.S. Patent No. 8,206,987 ("the '987 patent").
Contribution Of Elements Of Invention Used To Distinguish Invention From Prior Art Is Sufficient For Inventorship
In Blue Gentian, LLC v. Tristar Products, Inc., No.2021-2316 (Fed. Cir. June 9, 2023), the Federal Circuit affirmed a district court's judgement regarding correction of inventorship under 35 U.S.C. § 256. Blue Gentian sued Tristar for infringement of several design and utility patents related to an expandable hose. Tristar counterclaimed to correct inventorship of all the patents to include Mr. Ragner as a named inventor.
A Close Case: Federal Circuit Affirms Board Decision Finding Unusually Strong Objective Evidence Of Nonobviousness
On June 5, the Federal Circuit issued two decisions affirming the Board's findings of nonobviousness in Medtronic, Inc. v. Teleflex Innovations S.A.R.L, No. 2021-2357 (Fed. Cir. Jun. 5, 2023) and Medtronic, Inc. v. Teleflex Innovations S.A.R.L, No. 2021-2359 (Fed. Cir. Jun. 5, 2023). Medtronic requested inter partes reviews of several Teleflex patents relating to cardiac catheters at the Patent Trial and Appeal Board.
Spotlight On Upcoming Oral Arguments – June 2023 - Patent - United States
The following arguments will be available to the public live, both in-person and through online audio streaming. Access information will be available by 9 AM ET each day of argument at: https://cafc.uscourts.gov/home/oral-argument/listen-to-oral-arguments/. Tuesday, June 6, 2023 Axonics, Inc. v. Medtronic, Inc., No. 22-1532, Courtroom 402 In IPR proceedings, Axonics challenged the patentability of certain claims in two patents owned by Medtronic.
Anomalous Infrared Intensity Behavior of Acetonitrile Diffused into UiO-67
Download Hi-Res ImageDownload to MS-PowerPointCite This:Chem. Mater. 2023, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
Lidl is to invest £4bn in UK food producers in 2023
Lidl GB added that the move will accelerate previously announced spending plans. Lidl has said it will invest £4 billion into UK food businesses this year as it pushes forward with growth plans. Lidl GB added that the move will accelerate previously announced spending plans. In 2019, the British arm of the German discount retailer committed to £15 billion of investment in the UK food industry from 2020 to 2025. The group said this is now expected to rise to £17 billion for the period.
Accelerating Patent Eligibility Decisions At The ITC
United States: Accelerating Patent Eligibility Decisions At The ITC 22 September 2021 by Eric J. Fues and Ryan McDonnell Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com.
Needham guest columns: New construction has many benefits
Sign up for our newsletter and have the top headlines from your community delivered right to your inbox.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack